An analysis of late deaths after liver transplantation

Transplantation

Volumn 61, Issue 9, 1996, Pages 1377-1381

  Asfar, Sami ^a   Metrakos, Peter ^a   Fryer, Jonathan ^a   Verran, Deborah ^a   Ghent, Cameron ^a   Grant, David ^a   Bloch, Michael ^a   Burns, Patsy ^a   Wall, William ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT ATRESIA; BUDD CHIARI SYNDROME; CANCER RECURRENCE; CAUSE OF DEATH; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL TIME;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0029880981     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00016     Document Type: Article

References (37)

1. Starzl TE, Demetris AJ. Liver transplantation: a 31-year perspective Part III. Curr Prob Surg 1990; 4: 202.
2. Busuttil RW, Shaked A, Millis JM, et al. One thousand liver transplants, the lessons learned. Ann Surg 1994; 219: 490.
3. Harrison JD, Mirza DF, Gunson BK, Mayer AD, Buckels JAC, McMaster P. Development of indications and results during 10 years of orthotopic liver transplantation. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 153.
4. Terasaki PI, Cecka JM, Eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 704.
5. Cuervas-Mons V, Martinez AJ, Dekker A, Starzl TE, Van Thiel DH. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology 1986; 6(3): 495.
6. Clavien PA, Camargo CA Jr, Croxford R, Langer B, Levy GA, Greig PD. Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 1994; 220: 109.
7. Shaw BW, Wood P, Stratta RJ, Pillen TJ, Langnas AN. Stratifying the causes of death in liver transplant recipients. Arch Surg 1989; 124: 895.
8. Adams PC, Ghent CN, Grant DR, Wall WJ. Employment after liver transplantation. Hepatology 1995; 21: 140.
9. Levy MF, Jennings L, Abouljoud MS, et al. Quality of life improvements at one, two and five years after liver transplantation. Transplantation 1995; 59: 515.
10. Grant DR, Wall WJ, Ghent CN, et al. Liver transplantation: the problem of rejection. Transplant Proc 1986; 18: 163.
11. Wall WJ, Ghent CN, Roy A, McAlister VC, Grant DR, Adams PC. Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation. Dig Dis Sci 1995; 40: 52.
12. Iwatsuki S, Starzl TE, Gordon RD, et al. Late mortality and morbidity after liver transplantation. Transplant Proc 1987; 19: 2373.
13. Backman L, Gibbs J, Levy M, et al. Causes of late graft loss after liver transplantation. Transplantation 1993; 55: 1078.
14. Schweitzer EJ, Matas AJ, Gillingham KJ, et al. Causes of renal allograft loss: progress in 1980s, challenges for the 1990s. Ann Surg 1991; 214; 679.
15. Gray JR, Kasiske BL. Patient and renal allograft survival in the late post-transplant period. Semin Nephrol 1992; 12: 343.
16. Bradley BA, Gilks WR, Gore SM. A preliminary analysis of late renal allograft failure. In: Terasaki PI, ed. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1990: 175.
17. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection - an undefined conundrum. Transplantation 1991; 52: 389.
18. Demetris AJ, Fung JJ, Todo S, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy: a clinicopathologic study of 95 patients. Transplantation 1992; 53: 1056.
19. Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 1995; 59: 460.
20. Powelson JA, Cosimi B, Lewis WD, et al. Hepatic retransplantation in New England - a regional experience and survival model. Transplantation 1993; 55: 802.
21. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59: 212.
22. Reyes J, Zeevi A, Ramos H, et al. Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 1993; 25: 3315.
23. Devlin J, Slapak G, Portmann B, Williams R. Immunosuppression withdrawal in long-term liver recipients. Hepatology 1994; 20: 124A.
24. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung J, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619.
25. Jurim O, Martin P, Shaked A, et al. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994; 57: 1393.
26. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
27. Marcellin P, Samuel D, Areias J, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 6.
28. Gretch DR, Bacchi CE, Corey L, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995; 22: 1.
29. Terrault NA, Wright TL. Hepatitis C virus in the setting or transplantation. Semin Liver Dis 1995; 15: 92.
30. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221.
31. Pichlmayr R. Is there a place for liver grafting in malignancy? Transplant Proc 1988; 20: 478.
32. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270.
33. Chung SW, Toth JL, Rezieg M, et al. Liver transplantation for hepatocellular carcinoma. Am J Surg 1994; 167: 317.
34. Stone M, Klintmalm G, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104: 196.
35. Carr BI. High objective response rates of advanced hepatocellular carcinoma to intra-arterial chemotherapy. Proc ASCO 1992; 11: 470.
36. Izumi R, Shimizu K, Iyobe T, et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anti-cancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20: 295.
37. Olthoff KM, Rosove MH, Shackleton CR, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995; 221: 734.